Boundless Bio Financial Ratios for Analysis 2022-2024 | BOLD

Fifteen years of historical annual and quarterly financial ratios and margins for Boundless Bio (BOLD).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
13.278.80
-0.04
0.020.08
--
--
--
--
--
--
--
--
--
--
38.9056.19
-41.01-69.28
-38.06-59.74
-41.01-66.43
96.6656.77
-38.53-36.06
-39.05-37.03

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-06-302024-03-312023-12-312023-06-302023-03-312022-12-31
20.4510.54----
------
0.000.01----
------
------
------
------
------
------
------
------
------
------
-9.4710.93----
-9.47-14.50----
-9.02-13.18----
-9.47-14.50----
8.0584.27----
-1.45-12.540.00-19.05-10.220.00
-1.53-12.61--19.23-10.29-